MyFinsight
Home
Blog
About
Short-term investments
$1,704,520K
(-14.46%↓ Y/Y)
Cash and cash
equivalents
$350,065K
(17.75%↑ Y/Y)
Other current assets
$327,011K
(44.63%↑ Y/Y)
Contracts receivable
$58,845K
(11.92%↑ Y/Y)
Inventories
$50,833K
(499.38%↑ Y/Y)
Total current assets
$2,491,274K
(-3.33%↓ Y/Y)
Right-of-use assets
$231,560K
(41.25%↑ Y/Y)
Property, plant and
equipment, net
$155,131K
(38.57%↑ Y/Y)
Deposits and other assets
$116,536K
(-11.78%↓ Y/Y)
Total assets
$2,994,501K
(0.31%↑ Y/Y)
Total liabilities and
stockholders equity
$2,994,501K
(0.31%↑ Y/Y)
Total liabilities
$2,554,764K
(8.56%↑ Y/Y)
Total stockholders'
equity
$439,737K
(-30.39%↓ Y/Y)
Accumulated deficit
-$2,838,369K
(-24.86%↓ Y/Y)
Accumulated other
comprehensive loss
-$33,897K
(-21.12%↓ Y/Y)
Convertible senior notes,
net-Convertible Senior Notes...
$753,356K
Convertible senior notes,
net-Convertible Senior Notes...
$569,255K
Liability related to sale
of future...
$562,574K
(3.95%↑ Y/Y)
Total current
liabilities
$315,638K
(-64.82%↓ Y/Y)
Long-term lease
liabilities
$262,476K
(59.68%↑ Y/Y)
Long-term deferred
contract revenue
$63,030K
(-49.61%↓ Y/Y)
Long-term obligations
$28,435K
(-51.87%↓ Y/Y)
Additional paid-in capital
$3,311,837K
(12.93%↑ Y/Y)
Common stock, 0.001 par
value 300,000,000...
$166K
(4.40%↑ Y/Y)
Accrued liabilities
$115,778K
(17.00%↑ Y/Y)
Current portion of
deferred contract...
$73,837K
(-2.73%↓ Y/Y)
Accrued compensation
$50,293K
(8.01%↑ Y/Y)
Accounts payable
$47,704K
(109.23%↑ Y/Y)
Other current
liabilities
$25,149K
(10.27%↑ Y/Y)
Income taxes payable
$2,877K
(3451.85%↑ Y/Y)
Back
Back
Balance Sheet
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)
source: myfinsight.com